FDA product code PQX: Epinephrine Syringe

PQX is the FDA product code for epinephrine syringe. It is a Class II device, regulated under 21 CFR 880.5860 and reviewed by the General Hospital panel. FDA has cleared 2 510(k) submissions under PQX. The average 510(k) review took 280 days (median 280).

Definition

Intended for intramuscular or subcutaneous injection of epinephrine.

Classification

FieldValue
Device nameEpinephrine Syringe
Device classClass II
Regulation21 CFR 880.5860
Review panelHO — General Hospital
Medical specialtyGeneral Hospital
Premarket route510(k)

510(k) clearances per year for PQX

YearClearancesAvg. review days
20171324
20181237

Compare with all 510(k) review times · Search every PQX clearance

Top PQX applicants

ApplicantClearancesLatest
Certa Dose, Inc.22018-11-07

Most recent PQX clearances

510(k)ApplicantDeviceDecision dateReview days
K180683Certa Dose, Inc.Certa Dose Pediatric Midazolam 5mg/mL IM Syringe2018-11-07237
K160589Certa Dose, Inc.Certa Dose PD Epinephrine 1mg/mL IM/SC Syringe2017-01-19324

Recalls for PQX devices

openFDA lists no recalls for product code PQX.

Frequently asked questions

What is FDA product code PQX?

PQX is the FDA product code for epinephrine syringe. It is a Class II device, regulated under 21 CFR 880.5860 and reviewed by the General Hospital panel.

What device class is PQX?

Class II, regulation 21 CFR 880.5860. Typical premarket route: 510(k).

How long does a 510(k) take for product code PQX?

Across 2 cleared submissions the average was 280 days from receipt to decision (median 280).

Which companies have the most PQX clearances?

Certa Dose, Inc. (2).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All General Hospital product codes · FDA product code lookup · 510(k) database search · 510(k) review times